...
首页> 外文期刊>Comparative Medicine >A New Apparatus and Surgical Technique for the Dual Perfusion of Human Tumor Xenografts in Situ in Nude Rats
【24h】

A New Apparatus and Surgical Technique for the Dual Perfusion of Human Tumor Xenografts in Situ in Nude Rats

机译:裸鼠原位双重灌注人肿瘤异种移植物的新器械和手术技术

获取原文
获取原文并翻译 | 示例

摘要

We present a new perfusion system and surgical technique for simultaneous perfusion of 2 tissue-isolated human cancer xenografts in nude rats by using donor blood that preserves a continuous flow. Adult, athymic nude rats (Hsd:RH-Foxn1(rnu)) were implanted with He La human cervical or HT29 colon adenocarcinomas and grown as tissue-isolated xenografts. When tumors reached an estimated weight of 5 to 6 g, rats were prepared for perfusion with donor blood and arteriovenous measurements. The surgical procedure required approximately 20 min to complete for each tumor, and tumors were perfused for a period of 150 min. Results showed that tumor venous blood flow, glucose uptake, Lactic acid release, O-2 uptake and CO2 production, uptake of total fatty acid and linoleic acid and conversion to the mitogen 13-HODE, cAMP levels, and activation of several marker kinases were all well within the normal physiologic, metabolic, and signaling parameters characteristic of individually perfused xenografts. This new perfusion system and technique reduced procedure time by more than 50%. These findings demonstrate that 2 human tumors can be perfused simultaneously in situ or ex vivo by using either rodent or human blood and suggest that the system may also be adapted for use in the dual perfusion of other organs. Advantages of this dual perfusion technique include decreased anesthesia time, decreased surgical manipulation, and increased efficiency, thereby potentially reducing the numbers of laboratory animals required for scientific investigations.
机译:我们提出了一种新的灌注系统和外科手术技术,通过使用保留连续血流的供体血液,在裸鼠中同时灌注2种组织隔离的人类癌症异种移植物。将成年无胸腺裸鼠(Hsd:RH-Foxn1(rnu))植入He La人宫颈癌或HT29结肠腺癌,并作为组织隔离异种移植进行生长。当肿瘤达到估计的5至6 g重量时,准备用供血和动静脉测量灌注大鼠。手术过程大约需要20分钟才能完成,每个肿瘤的灌注时间为150分钟。结果显示,肿瘤静脉血流量,葡萄糖摄取,乳酸释放,O-2摄取和CO2产生,总脂肪酸和亚油酸的摄取以及转化为有丝分裂原13-HODE,cAMP水平以及几种标记激酶的活化是所有这些都在单独灌注异种移植物的正常生理,代谢和信号传递参数范围内。这种新的灌注系统和技术将手术时间减少了50%以上。这些发现表明,可以通过使用啮齿动物或人血同时在原位或离体同时灌注2种人类肿瘤,这表明该系统也可以适用于其他器官的双重灌注。这种双重灌注技术的优点包括减少麻醉时间,减少手术操作和提高效率,从而有可能减少科学研究所需的实验动物数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号